Aligned Genetics, Inc. (KOSDAQ:238120)
South Korea · Delayed Price · Currency is KRW 4,335.00
+60.00 (1.40%)
At close: Apr 24, 2026
Aligned Genetics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,911 | 4,128 | 3,236 | 2,333 | 5,542 |
Depreciation & Amortization | 608.95 | 575.74 | 631.38 | 650.38 | 538.59 |
Loss (Gain) From Sale of Assets | -10.78 | - | -4.5 | - | -13.94 |
Loss (Gain) From Sale of Investments | 178.26 | 7.44 | -34.04 | 591.23 | -1,686 |
Loss (Gain) on Equity Investments | - | 29.26 | 181.79 | -80.52 | 178.96 |
Provision & Write-off of Bad Debts | 20.68 | -2.79 | -0.55 | -11.88 | 2.97 |
Other Operating Activities | 537.39 | -739.87 | 487.38 | 417.53 | 99.1 |
Change in Accounts Receivable | 193.55 | 82.54 | -1,214 | 717.6 | -2,025 |
Change in Inventory | -813.88 | -119.94 | -55.66 | -1,407 | -337.39 |
Change in Accounts Payable | 50.29 | -219.98 | 14.31 | -53.19 | 1,017 |
Change in Unearned Revenue | - | -18.91 | 9.86 | - | - |
Change in Other Net Operating Assets | -66.84 | -699.56 | -452.6 | -1,084 | -1,409 |
Operating Cash Flow | 3,605 | 3,065 | 2,849 | 2,222 | 135.97 |
Operating Cash Flow Growth | 17.61% | 7.61% | 28.18% | 1534.52% | 281.17% |
Capital Expenditures | -11,065 | -257.69 | -878.54 | -2,001 | -3,307 |
Sale of Property, Plant & Equipment | - | - | 12.98 | - | 32.25 |
Sale (Purchase) of Intangibles | -45.15 | -145.75 | -1.87 | -2.23 | - |
Sale (Purchase) of Real Estate | -5,997 | - | - | - | -1,557 |
Investment in Securities | 7,500 | -7,011 | 1,502 | 4,000 | 248.18 |
Other Investing Activities | 232.27 | 282.35 | 655.49 | 555.69 | 916.01 |
Investing Cash Flow | -9,068 | -7,545 | 1,290 | 2,537 | -3,668 |
Short-Term Debt Issued | - | - | - | - | 978 |
Long-Term Debt Issued | 12,000 | 2,400 | - | - | 3,900 |
Total Debt Issued | 12,000 | 2,400 | - | - | 4,878 |
Short-Term Debt Repaid | - | - | - | - | -978 |
Long-Term Debt Repaid | -270.9 | -4,130 | -192.75 | -176.33 | -267.41 |
Total Debt Repaid | -270.9 | -4,130 | -192.75 | -176.33 | -1,245 |
Net Debt Issued (Repaid) | 11,729 | -1,730 | -192.75 | -176.33 | 3,633 |
Repurchase of Common Stock | -997.53 | - | - | - | - |
Other Financing Activities | -0 | - | - | - | - |
Financing Cash Flow | 10,732 | -1,730 | -192.75 | -176.33 | 3,633 |
Foreign Exchange Rate Adjustments | -790.14 | 1,422 | 284.86 | -24.31 | 397.42 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | -0 |
Net Cash Flow | 4,479 | -4,788 | 4,231 | 4,559 | 498.31 |
Free Cash Flow | -7,459 | 2,808 | 1,970 | 220.98 | -3,171 |
Free Cash Flow Growth | - | 42.52% | 791.50% | - | - |
Free Cash Flow Margin | -46.58% | 17.79% | 12.95% | 1.61% | -26.96% |
Free Cash Flow Per Share | -527.80 | 195.20 | 137.01 | 15.37 | -220.57 |
Cash Interest Paid | 85.76 | 138.56 | 190.05 | 165.3 | 28.88 |
Cash Income Tax Paid | 130.97 | 122.89 | 169 | 49.25 | 113.39 |
Levered Free Cash Flow | -9,116 | 1,112 | 947.12 | -388.58 | -2,676 |
Unlevered Free Cash Flow | -9,051 | 1,217 | 1,081 | -284.86 | -2,658 |
Change in Working Capital | -640.76 | -932.52 | -1,649 | -1,677 | -4,526 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.